共 40 条
Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial
被引:153
作者:
Krekel, Nicole M. A.
[1
]
Haloua, Max H.
[1
]
Cardozo, Alexander M. F. Lopes
[4
]
de Wit, Roos H.
[4
]
Bosch, Anne Marie
[5
]
de Widt-Levert, Louise M.
[6
]
Muller, Sandra
[7
]
van der Veen, Henk
[7
]
Bergers, Elisabeth
[2
]
de Klerk, Elly S. M. de Lange
[3
]
Meijer, Sybren
[1
]
van den Tol, M. Petrousjka
[1
]
机构:
[1] Vrije Univ Amsterdam, Med Ctr, Dept Surg Oncol, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, NL-1081 HV Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
[4] Med Ctr Alkmaar, Dept Surg, Alkmaar, Netherlands
[5] Gelderse Vallei Hosp, Dept Surg, Ede, Netherlands
[6] Waterland Hosp, Dept Surg, Purmerend, Netherlands
[7] Red Cross Hosp, Dept Surg, Beverwijk, Netherlands
关键词:
CONSERVING SURGERY;
SURGICAL MARGINS;
GUIDED LUMPECTOMY;
NEEDLE LOCALIZATION;
CONSERVATION;
CARCINOMA;
THERAPY;
FEASIBILITY;
GUIDELINES;
RESECTION;
D O I:
10.1016/S1470-2045(12)70527-2
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background Breast-conserving surgery for palpable breast cancer is associated with tumour-involved margins in up to 41% of cases and excessively large excision volumes. Ultrasound-guided surgery has the potential to resolve both of these problems, thereby improving surgical accuracy for palpable breast cancer. We aimed to compare ultrasound-guided surgery with the standard for palpable breast cancer-palpation-guided surgery-with respect to margin status and extent of healthy breast tissue resection. Methods In this randomised controlled trial, patients with palpable T1-T2 invasive breast cancer were recruited from six medical centres in the Netherlands between October, 2010, and March, 2012. Eligible participants were randomly assigned to either ultrasound-guided surgery or palpation-guided surgery in a 1:1 ratio via a computer-generated random sequence and were stratified by study centre. Patients and investigators were aware of treatment assignments. Primary outcomes were surgical margin involvement, need for additional treatment, and excess healthy tissue resection (defined with a calculated resection ratio derived from excision volume and tumour diameter). Data were analysed by intention to treat. This trial is registered at http://www.TrialRegister.nl, number NTR2579. Findings 134 patients were eligible for random allocation. Two (3%) of 65 patients allocated ultrasound-guided surgery had tumour-involved margins compared with 12 (17%) of 69 who were assigned palpation-guided surgery (difference 14%, 95% CI 4-25; p=0.0093). Seven (11%) patients who received ultrasound-guided surgery and 19 (28%) of those who received palpation-guided surgery required additional treatment (17%, 3-30; p=0.015). Ultrasound-guided surgery also resulted in smaller excision volumes (38 [SD 26] vs 57 [41] cm(3); difference 19 cm 3, 95% CI 7-31; p=0.002) and a reduced calculated resection ratio (1.0 [SD 0.5] vs 1.7 [1.2]; difference 0.7, 95% CI 0.4-1.0; p=0.0001) compared with palpation-guided surgery. Interpretation Compared with palpation-guided surgery, ultrasound-guided surgery can significantly lower the proportion of tumour-involved resection margins, thus reducing the need for re-excision, mastectomy, and radiotherapy boost. By achieving optimum resection volumes, ultrasound-guided surgery reduces unnecessary resection of healthy breast tissue and could contribute to improved cosmetic results and quality of life. Funding Dutch Pink Ribbon Foundation, Osinga-Kluis Foundation, Toshiba Medical Systems.
引用
收藏
页码:48 / 54
页数:7
相关论文